All CD4+IFNγ-/- T cell recipients that finally succumbed to the infection continuously lost weight and developed a clinical score with similar kinetics or even a little earlier than control mice, whether treated with isotype or anti-TNFα antibody (Fig 7B). Here, CD4 is linked to infection.